9,350
Total Claims
$1.3M
Drug Cost
606
Beneficiaries
$2,194
Cost/Patient
Peer Comparison vs. 106,889 Family Practice providers
-93%
Opioid rate vs peers
0.2% vs 2.6% avg
+105%
Cost per patient vs peers
$2,194 vs $1,068 avg
+75%
Brand preference vs peers
15.7% vs 9.0% avg
Opioid Prescribing
0.2%
Opioid Rate
17
Opioid Claims
$100
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
84% generic
Brand: 1,443 claims · $1.2M
Generic: 7,735 claims · $145K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 183 | $260K |
| Linagliptin | 82 | $118K |
| Insulin Glargine,hum.Rec.Anlog | 154 | $85K |
| Apixaban | 57 | $68K |
| Semaglutide | 50 | $67K |
| Sitagliptin Phosphate | 42 | $61K |
| Dulaglutide | 32 | $54K |
| Insulin Glargine,hum.Rec.Anlog | 21 | $24K |
| Insulin Lispro Protamin/Lispro | 22 | $24K |
| Insulin Aspart | 30 | $22K |
| Mirabegron | 23 | $21K |
| Rivaroxaban | 21 | $20K |
| Semaglutide | 13 | $19K |
| Sitagliptin Phos/Metformin Hcl | 18 | $17K |
| Insulin Lispro | 24 | $15K |
Prescribing Profile
Patient Profile
72
Avg Age
44%
Female
1.09
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data